<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="jah38832" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id><journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id><journal-id journal-id-type="pmc-domain-id">1888</journal-id><journal-id journal-id-type="pmc-domain">jaha</journal-id><journal-id journal-id-type="publisher-id">JAH3</journal-id><journal-title-group><journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title></journal-title-group><issn pub-type="epub">2047-9980</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10727253</article-id><article-id pub-id-type="pmcid-ver">PMC10727253.1</article-id><article-id pub-id-type="pmcaid">10727253</article-id><article-id pub-id-type="pmcaiid">10727253</article-id><article-id pub-id-type="pmid">37750568</article-id><article-id pub-id-type="doi">10.1161/JAHA.123.030009</article-id><article-id pub-id-type="publisher-id">JAH38832</article-id><article-id pub-id-type="other">JAHA/2023/030009</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject><subj-group subj-group-type="heading"><subject>Stroke</subject></subj-group></subj-group></article-categories><title-group><article-title>Misdiagnosis of Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome in the Emergency Department</article-title><alt-title alt-title-type="right-running-head">Misdiagnosis of <styled-content style="fixed-case" toggle="no">PRES</styled-content>/<styled-content style="fixed-case" toggle="no">RCVS</styled-content> in the <styled-content style="fixed-case" toggle="no">ED</styled-content></alt-title><alt-title alt-title-type="left-running-head">Liberman et al</alt-title></title-group><contrib-group><contrib id="jah38832-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Liberman</surname><given-names initials="AL">Ava L.</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0184-6035</contrib-id><xref rid="jah38832-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>all9188@med.cornell.edu</email></address></contrib><contrib id="jah38832-cr-0002" contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="C">Cenai</given-names></name><degrees>MS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8137-1644</contrib-id><xref rid="jah38832-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jah38832-cr-0003" contrib-type="author"><name name-style="western"><surname>Parikh</surname><given-names initials="NS">Neal S.</given-names></name><degrees>MD, MS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8802-2380</contrib-id><xref rid="jah38832-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jah38832-cr-0004" contrib-type="author"><name name-style="western"><surname>Salehi Omran</surname><given-names initials="S">Setareh</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3184-5327</contrib-id><xref rid="jah38832-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jah38832-cr-0005" contrib-type="author"><name name-style="western"><surname>Navi</surname><given-names initials="BB">Babak B.</given-names></name><degrees>MD, MS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8424-6128</contrib-id><xref rid="jah38832-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jah38832-cr-0006" contrib-type="author"><name name-style="western"><surname>Lappin</surname><given-names initials="RI">Richard I.</given-names></name><degrees>MD, PhD</degrees><xref rid="jah38832-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jah38832-cr-0007" contrib-type="author"><name name-style="western"><surname>Merkler</surname><given-names initials="AE">Alexander E.</given-names></name><degrees>MD, MS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2211-299X</contrib-id><xref rid="jah38832-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jah38832-cr-0008" contrib-type="author"><name name-style="western"><surname>Kaiser</surname><given-names initials="JH">Jed H.</given-names></name><degrees>BS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4955-8606</contrib-id><xref rid="jah38832-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jah38832-cr-0009" contrib-type="author"><name name-style="western"><surname>Kamel</surname><given-names initials="H">Hooman</given-names></name><degrees>MD, MS</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5745-0307</contrib-id><xref rid="jah38832-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="jah38832-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Clinical and Translational Neuroscience Unit, Department of Neurology</named-content>
<institution>Feil Family Brain and Mind Research Institute, Weill Cornell Medicine</institution>
<city>New York</city>
<named-content content-type="country-part">NY</named-content>
</aff><aff id="jah38832-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Neurology</named-content>
<institution>University of Colorado School of Medicine</institution>
<city>Aurora</city>
<named-content content-type="country-part">CO</named-content>
</aff><aff id="jah38832-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Emergency Medicine</named-content>
<institution>Weill Cornell Medicine</institution>
<city>New York</city>
<named-content content-type="country-part">NY</named-content>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Correspondence to: Ava L. Liberman, MD, Weill Cornell Medicine, 520 East 70th Street, Starr 607, New York, NY 10021.<break/> Email: <email>all9188@med.cornell.edu</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>9</month><year>2023</year></pub-date><pub-date pub-type="collection"><day>03</day><month>10</month><year>2023</year></pub-date><volume>12</volume><issue seq="320">19</issue><issue-id pub-id-type="pmc-issue-id">451241</issue-id><issue-id pub-id-type="doi">10.1002/jah3.v12.19</issue-id><elocation-id>e030009</elocation-id><history><date date-type="received"><day>28</day><month>2</month><year>2023</year></date><date date-type="accepted"><day>24</day><month>8</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>10</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>19</day><month>12</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-01-29 04:25:17.850"><day>29</day><month>01</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non&#8208;commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JAH3-12-e030009.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:JAH3-12-e030009.pdf"/><abstract><sec id="jah38832-sec-0001"><title>Background</title><p>Cerebrovascular dysregulation syndromes, posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS), are challenging to diagnose because they are rare and require advanced neuroimaging for confirmation. We sought to estimate PRES/RCVS misdiagnosis in the emergency department and its associated factors.</p></sec><sec id="jah38832-sec-0002"><title>Methods and Results</title><p>We conducted a retrospective cohort study of PRES/RCVS patients using administrative claims data from 11 states (2016&#8211;2018). We defined patients with a probable PRES/RCVS misdiagnosis as those with an emergency department visit for a neurological symptom resulting in discharge to home that occurred &#8804;14&#8201;days before PRES/RCVS hospitalization. Proportions of patients with probable misdiagnosis were calculated, characteristics of patients with and without probable misdiagnosis were compared, and regression analyses adjusted for demographics and comorbidities were performed to identify factors affecting probable misdiagnosis. We identified 4633 patients with PRES/RCVS. A total of 210 patients (4.53% [95% CI, 3.97&#8211;5.17]) had a probable preceding emergency department misdiagnosis; these patients were younger (mean age, 48 versus 54 years; <italic toggle="no">P</italic>&lt;0.001) and more often female (80.4% versus 69.3%; <italic toggle="no">P</italic>&lt;0.001). Misdiagnosed patients had fewer vascular risk factors except prior stroke (36.3% versus 24.2%; <italic toggle="no">P</italic>&lt;0.001) and more often had comorbid headache (84% versus 21.4%; <italic toggle="no">P</italic>&lt;0.001) and substance use disorder (48.8% versus 37.9%; <italic toggle="no">P</italic>&lt;0.001). Facility&#8208;level factors associated with probable misdiagnosis included smaller facility, lacking a residency program (62.2% versus 73.7%; <italic toggle="no">P</italic>&lt;0.001), and not having on&#8208;site neurological services (75.7% versus 84.3%; <italic toggle="no">P</italic>&lt;0.001). Probable misdiagnosis was not associated with higher likelihood of stroke or subarachnoid hemorrhage during PRES/RCVS hospitalization.</p></sec><sec id="jah38832-sec-0003"><title>Conclusions</title><p>Probable emergency department misdiagnosis occurred in &#8776;1 of every 20 patients with PRES/RCVS in a large, multistate cohort.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="jah38832-kwd-0001">diagnostic error</kwd><kwd id="jah38832-kwd-0002">emergency medicine</kwd><kwd id="jah38832-kwd-0003">posterior reversible encephalopathy syndrome</kwd><kwd id="jah38832-kwd-0004">reversible cerebral vasoconstriction syndrome</kwd><kwd id="jah38832-kwd-0005">stroke</kwd></kwd-group><kwd-group kwd-group-type="subject-categories"><title>Subject Categories</title><kwd>Cerebrovascular Disease/Stroke</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Institute on Aging
</institution><institution-id institution-id-type="doi">10.13039/100000049</institution-id></institution-wrap></funding-source><award-id>K23AG073524</award-id></award-group><award-group id="funding-0002"><funding-source>Florence Gould Foundation</funding-source></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>National Institute of Neurological Disorders and Stroke
</institution><institution-id institution-id-type="doi">10.13039/100000065</institution-id></institution-wrap></funding-source><award-id>K23NS10764</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="8"/><word-count count="4848"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>03 October 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.5 mode:remove_FC converted:30.11.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="jah38832-ntgp-0001"><fn id="jah38832-note-0001"><p>This manuscript was sent to Jose R. Romero, MD, Associate Editor, for review by expert referees, editorial decision, and final disposition.</p></fn><fn id="jah38832-note-0002"><p>For Sources of Funding and Disclosures, see page 7.</p></fn></fn-group></notes></front><body id="jah38832-body-0001"><def-list list-content="abbreviations" id="jah38832-lp-0001"><title>Nonstandard Abbreviations and Acronyms</title><def-item><term id="jah38832-li-0001">HCUP</term><def id="jah38832-li-0002"><p>Healthcare Cost and Utilization Project</p></def></def-item><def-item><term id="jah38832-li-0003">PRES</term><def id="jah38832-li-0004"><p>posterior reversible encephalopathy syndrome</p></def></def-item><def-item><term id="jah38832-li-0005">RCVS</term><def id="jah38832-li-0006"><p>reversible cerebral vasoconstriction syndrome</p></def></def-item></def-list><p>
<boxed-text position="anchor" content-type="box" id="jah38832-blkfxd-0001" orientation="portrait"><caption><title>Clinical Perspective</title></caption><sec id="jah38832-sec-0006"><title>What Is New?</title><p>
<list list-type="bullet" id="jah38832-list-0001"><list-item id="jah38832-li-0007"><p>In a population&#8208;level cohort study of patients hospitalized for posterior reversible encephalopathy syndrome/reversible cerebral vasoconstriction syndrome, nearly 5% had a probable preceding emergency department misdiagnosis.</p></list-item><list-item id="jah38832-li-0008"><p>Probable emergency department misdiagnosis of posterior reversible encephalopathy syndrome/reversible cerebral vasoconstriction syndrome was not significantly associated with the assessed markers of adverse clinical outcomes during subsequent posterior reversible encephalopathy syndrome/reversible cerebral vasoconstriction syndrome hospitalization.</p></list-item></list>
</p></sec><sec id="jah38832-sec-0007"><title>What Are the Clinical Implications?</title><p>
<list list-type="bullet" id="jah38832-list-0002"><list-item id="jah38832-li-0009"><p>Increased suspicion for posterior reversible encephalopathy syndrome/reversible cerebral vasoconstriction syndrome in young emergency department patients presenting with neurological symptoms, particularly headache, may be warranted.</p></list-item></list>
</p></sec></boxed-text>
</p><p>Over the past few years, several cohort studies have characterized posterior reversible encephalopathy syndrome (PRES)<xref rid="jah38832-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="jah38832-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> and reversible cerebral vasoconstriction syndrome (RCVS),<xref rid="jah38832-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="jah38832-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> leading to an increased recognition of these 2 entities as cerebrovascular dysregulation syndromes with overlapping presenting symptoms and a shared pathophysiology of transiently impaired cerebral autoregulation.<xref rid="jah38832-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> Despite our improved understating of these diseases, diagnosing PRES or RCVS is complicated by the relative rarity of these conditions, the need for advanced neuroimaging for confirmation, and the lack of well&#8208;established diagnostic criteria for PRES/RCVS.<xref rid="jah38832-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="jah38832-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="jah38832-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="jah38832-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> Rates of misdiagnosis of these cerebrovascular dysregulation syndromes are not well quantified, though rates of misdiagnosis of other cerebrovascular diseases in the emergency setting range from 3% to 9%.<xref rid="jah38832-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="jah38832-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> Understanding current patterns of acute misdiagnosis among patients with PRES/RCVS is an essential first step toward improving diagnostic quality and safety for these patients.<xref rid="jah38832-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="jah38832-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> We therefore sought to evaluate rates of probable PRES/RCVS misdiagnosis in the emergency department (ED) at the population level. We also sought to identify patient&#8208; and facility&#8208;level factors associated with misdiagnosis as well as to assess the impact of a probable ED misdiagnosis on subsequent clinical outcomes.</p><sec sec-type="methods" id="jah38832-sec-0008"><title>Methods</title><p>We followed the Strengthening the Reporting of Observational Studies in Epidemiology guidelines.<xref rid="jah38832-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> The data that support the findings of this study are publicly available from the Healthcare Cost and Utilization Project (HCUP) at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://hcup-us.ahrq.gov" ext-link-type="uri">https://hcup&#8208;us.ahrq.gov</ext-link>.</p><sec id="jah38832-sec-0009"><title>Design</title><p>We conducted a retrospective cohort study of patients with PRES, RCVS, or both using deidentified all&#8208;payer claims data from all nonfederal EDs and hospitals across 11 states. These data were obtained from the Agency for Healthcare Research and Quality and its HCUP database. The included states were Arkansas, Florida, Georgia, Iowa, Massachusetts, Maryland, Nebraska, New York, Utah, Vermont, and Wisconsin. These 11 states were chosen because they are the only ones that provide contemporary longitudinal data to HCUP, thereby enabling tracking of patients across multiple ED visits and hospital admissions using an anonymous personal linkage number.<xref rid="jah38832-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> This study was conducted from 2016 to 2018. The Weill Cornell Medicine Institutional Review Board approved this study and granted a waiver of informed consent.</p><p>In this study, we used the National Academies of Sciences, Engineering, and Medicine definition of diagnostic error as a failure to establish an accurate and timely explanation of a patient's health problem.<xref rid="jah38832-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> In keeping with prior research,<xref rid="jah38832-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> we defined a <italic toggle="yes">probable</italic> misdiagnosis of PRES/RCVS as when (1) an ED visit resulted in discharge to home (treat&#8208;and&#8208;release visit), (2) the primary ED discharge diagnosis was for a neurological symptom (eg, headache, dizziness, numbness) that could represent an early manifestation of PRES/RCVS, and (3) the ED discharge occurred in the 14&#8201;days before the PRES/RCVS hospitalization. We defined a <italic toggle="yes">possible</italic> ED misdiagnosis as any ED treat&#8208;and&#8208;release visit during the 14&#8201;days before a PRES/RCVS hospitalization because PRES/RCVS can initially manifest with systemic complaints (eg, elevated blood pressure).<xref rid="jah38832-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="jah38832-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> All other patients were considered as not having evidence of ED misdiagnosis (not misdiagnosed); patients with a cerebrovascular event during the 14&#8201;days before PRES/RCVS hospitalization were also considered not misdiagnosed, as these events can coincide with PRES/RCVS.</p><p>Measuring rates of diagnostic error or misdiagnosis using 2 points in time by pairing nonspecific symptoms initially thought to be benign with an unexpected adverse health event, as we do in this current study, is known as the Symptom&#8211;Disease Pair Analysis of Diagnostic Error conceptual approach.<xref rid="jah38832-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> This approach has been previously employed to measure rates of delayed cerebrovascular diagnoses using administrative claims data.<xref rid="jah38832-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="jah38832-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="jah38832-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Here, our direction of analysis is from hospitalization for PRES/RCVS to a preceding ED treat&#8208;and&#8208;release visit for a related symptom(s), which constitutes a look&#8208;back Symptom&#8211;Disease Pair Analysis of Diagnostic Error design.<xref rid="jah38832-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Using visits resulting in discharge to home to evaluate for potential diagnostic error is a popular strategy that relies on the presumption that patients sent home from the ED are those who are thought, at the time of their ED evaluation, to have a low&#8208;risk or benign condition that can be managed in the outpatient setting.</p></sec><sec id="jah38832-sec-0010"><title>Population</title><p>To identify hospitalized patients with PRES/RCVS, we used validated <italic toggle="yes">International Classification of Diseases, Tenth Revision, Clinical Modification</italic> (<italic toggle="yes">ICD&#8208;10&#8208;CM</italic>) codes I67.841 and I67.83. A previous multicenter chart review study found a sensitivity of 100% (95% CI, 82&#8211;100) and specificity of 90% (95% CI, 79&#8211;96) for the diagnostic code I67.841 to detect RCVS.<xref rid="jah38832-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> Similarly, the diagnostic code I67.83 for PRES was previously found to have a sensitivity of 100% (95% CI, 86.8&#8211;100) and a specificity of 88.2% (95% CI, 72.6&#8211;96.7).<xref rid="jah38832-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
</p></sec><sec id="jah38832-sec-0011"><title>Measurements</title><p>We defined ED treat&#8208;and&#8208;release visits for neurological symptoms as those with a primary <italic toggle="yes">ICD&#8208;10&#8208;CM</italic> discharge diagnosis code for any neurological issue (eg, headache, numbness, dizziness, or altered mental status). ED visits in which a cerebrovascular condition was diagnosed were defined using well&#8208;established <italic toggle="yes">ICD&#8208;10&#8208;CM</italic> codes.<xref rid="jah38832-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> ED treat&#8208;and&#8208;release visits for a nonneurological symptom were defined as those with a primary <italic toggle="yes">ICD&#8208;10&#8208;CM</italic> discharge diagnosis code for any nonneurological issue (eg, chest pain, vomiting).</p><p>We used <italic toggle="yes">ICD&#8208;10&#8208;CM</italic> codes recorded at the time of PRES/RCVS hospitalization to measure the following vascular comorbidities: hypertension, diabetes, coronary artery disease, congestive heart failure, atrial fibrillation/flutter, chronic obstructive pulmonary disease, chronic kidney disease, renal failure, and prior stroke.<xref rid="jah38832-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>, <xref rid="jah38832-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="jah38832-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> We also used <italic toggle="yes">ICD&#8208;10&#8208;CM</italic> codes recorded at the time of PRES/RCVS hospitalization to measure the following comorbidities and triggers previously associated with PRES/RCVS: primary headache disorder, substance&#8208;use disorder, drug poisoning, psychiatric illness, lupus, rheumatological disorders, cancer, and pregnancy/puerperium.<xref rid="jah38832-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref>
</p><p>To explore the impact of probable misdiagnosis on patients' outcomes, we determined the frequency of ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage (SAH) using highly reliable <italic toggle="yes">ICD&#8208;10&#8208;CM</italic> diagnostic codes recorded at the PRES/RCVS hospitalization.<xref rid="jah38832-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> We also calculated length of stay for PRES/RCVS hospitalization and recorded discharge disposition.</p><p>We used data from the American Hospital Association to determine each facility's bed size, teaching status, and availability of neurological services.</p></sec><sec id="jah38832-sec-0012"><title>Statistical Analysis</title><p>Standard descriptive statistics were used to characterize the study population, including means with SDs for normally distributed continuous variables and medians with interquartile ranges for nonnormally distributed continuous variables. The modified Wald method was used to determine CIs around our calculated proportions for misdiagnosis. To account for patients who had &gt;1 preceding ED visit within 14&#8201;days of their PRES/RCVS hospitalization, we weighted patient&#8208; and facility&#8208;level factors using visit frequency to identify factors associated with probable ED misdiagnosis. We compared patients with PRES/RCVS with a probable ED misdiagnosis to those without a misdiagnosis (not misdiagnosed). We also compared the ED facilities in which patients with a probable misdiagnosis had their treat&#8208;and&#8208;release visit(s) to the ED facilities in which patients without a probable misdiagnosis were seen. No adjustments were made for clustering of patients within a given ED.</p><p>Comparisons between groups were performed using the <italic toggle="yes">t</italic> test for continuous variables and &#967;<sup>2</sup> test for categorical variables. To evaluate the joint influence of patient and facility factors on probable ED misdiagnosis, we constructed a multivariable model where all factors significantly associated with misdiagnosis in univariate analyses were included as predictors. We used multiple logistic regression to assess the relationship between probable ED misdiagnosis and subsequent (at the PRES/RCVS hospitalization) stroke as well as discharge disposition (discharged to home versus all other destinations) using odds ratios (ORs). To perform robust regression inference, sandwich standard errors were used. Linear regression was used to evaluate length of stay during PRES/RCVS hospitalization between patients with versus without a probable ED misdiagnosis. We adjusted all models for patient demographics and comorbidities. We used linear regression and graphed a histogram to evaluate the timing of ED treat&#8208;and&#8208;release visits before PRES/RCVS hospitalization among patients with a probable misdiagnosis. The threshold for statistical significance was set as &lt;0.05. All tests of comparison were 2&#8208;sided. Analyses were performed using Stata/MP, version 15.1 (StataCorp, College Station, TX). All missing data elements are explicitly acknowledged; we did not impute any data. Cenai Zhang had full access to all the data in the study and takes responsibility for their integrity and the data analysis.</p></sec></sec><sec sec-type="results" id="jah38832-sec-0013"><title>Results</title><p>We identified 4633 patients hospitalized for PRES/RCVS; most (n=4169; 90.0%) had PRES. A total of 210 patients (4.5% [95% CI, 4.0&#8211;5.2]) had a probable ED misdiagnosis. A total of 615 patients (13.3% [95% CI, 12.3&#8211;14.3) had a possible ED misdiagnosis.</p><p>Among the 210 patients with a probable misdiagnosis, there were 281 ED treat&#8208;and&#8208;release visits in the 14&#8201;days before their PRES/RCVS hospitalization. There were 50 patients with a probable misdiagnosis who had &gt;1 ED treat&#8208;and&#8208;release visit before their PRES/RCVS hospitalization; the median number of preceding ED visits was 1 (interquartile range, 1&#8211;2). The 3 most common ED treat&#8208;and&#8208;release visits' primary diagnoses among patients with a probable misdiagnosis were&#160;headache, migraine headache, and unspecified altered mental status. ED visit frequency increased closer in time to the PRES/RCVS hospitalization; there were 51 relevant ED visits &#8804;1&#8201;day before PRES/RCVS hospitalization as opposed to only 17 visits on the 14th day before PRES/RCVS hospitalization (<italic toggle="yes">P</italic>&lt;0.001; <xref rid="jah38832-fig-0001" ref-type="fig">Figure</xref>).</p><fig position="float" fig-type="Figure" id="jah38832-fig-0001" orientation="portrait"><label>Figure 1</label><caption><title>Pattern of emergency department treat&#8208;and&#8208;release visits over time among patients with a probable misdiagnosis of PRES/RCVS.</title><p>Emergency department treat&#8208;and&#8208;release visits for neurological symptoms; day 0 corresponds to the day of PRES/RCVS hospitalization. PRES/RCVS indicates posterior reversible encephalopathy syndrome/reversible cerebral vasoconstriction syndrome.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="JAH3-12-e030009-g001.jpg"/></fig><p>Among the 210 patients with PRES/RCVS with a probable misdiagnosis, 120 (57.14%) had a final diagnosis of PRES only, and 84 (40%) had a final diagnosis of RCVS only. As shown in Table&#160;<xref rid="jah38832-tbl-0001" ref-type="table">1</xref>, patients with a probable misdiagnosis were younger (47.7&#8201;years versus 54&#8201;years; <italic toggle="yes">P</italic>&lt;0.001), more often women (80.4% versus 69.3%; <italic toggle="yes">P</italic>&lt;0.001), and more often had private insurance as compared with those correctly diagnosed. Vascular comorbidities were all significantly more common in patients correctly diagnosed except for history of prior stroke, which was more common in those with a probable misdiagnosis (36.3% versus 24.2%; <italic toggle="yes">P</italic>&lt;0.001). Patients with a probable misdiagnosis more often had a comorbid headache condition (84% versus 21.4%; <italic toggle="yes">P</italic>&lt;0.001) and substance use disorder (48.8% versus 37.9%; <italic toggle="yes">P</italic>&lt;0.001). Having a history of cancer (5% versus 13.1%; <italic toggle="yes">P</italic>&lt;0.001), rheumatological disorder (4.3% versus 7.6%; <italic toggle="yes">P</italic>=0.041), including lupus, as well as being pregnant or postpartum were less common among patients with a probable misdiagnosis.</p><table-wrap position="float" id="jah38832-tbl-0001" content-type="Table" orientation="portrait"><label>Table 1</label><caption><p>Differences Between Patients With Versus Without Probable Posterior Reversible Encephalopathy Syndrome/Reversible Cerebral Vasoconstriction Syndrome Misdiagnosis Weighted Using Visit Frequency</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">No misdiagnosis (N=4018)</th><th align="left" rowspan="1" colspan="1">Probable misdiagnosis (N=281)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1">Demographics</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Age, mean (SD), y</td><td align="left" rowspan="1" colspan="1">54.0 (18.5)</td><td align="left" rowspan="1" colspan="1">47.7 (15.1)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Sex, female, n (%)</td><td align="left" rowspan="1" colspan="1">2783 (69.3)</td><td align="left" rowspan="1" colspan="1">226 (80.4)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" colspan="4" rowspan="1">Race or ethnicity, n (%)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">White</td><td align="left" rowspan="1" colspan="1">2642 (65.8)</td><td align="left" rowspan="1" colspan="1">207 (73.7)</td><td align="left" rowspan="4" colspan="1">0.038</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Black</td><td align="left" rowspan="1" colspan="1">884 (22.0)</td><td align="left" rowspan="1" colspan="1">43 (15.3)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Hispanic</td><td align="left" rowspan="1" colspan="1">265 (6.6)</td><td align="left" rowspan="1" colspan="1">18 (6.4)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Other</td><td align="left" rowspan="1" colspan="1">227 (5.7)</td><td align="left" rowspan="1" colspan="1">13 (4.6)</td></tr><tr><td align="left" style="padding-left:10%" colspan="4" rowspan="1">Primary expected payer, n (%)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Medicare</td><td align="left" rowspan="1" colspan="1">1832 (45.6)</td><td align="left" rowspan="1" colspan="1">67 (23.8)</td><td align="left" rowspan="4" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Medicaid</td><td align="left" rowspan="1" colspan="1">823 (20.5)</td><td align="left" rowspan="1" colspan="1">71 (25.3)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Private insurance</td><td align="left" rowspan="1" colspan="1">1076 (26.8)</td><td align="left" rowspan="1" colspan="1">123 (43.8)</td></tr><tr><td align="left" style="padding-left:15%" rowspan="1" colspan="1">Other</td><td align="left" rowspan="1" colspan="1">287 (7.1)</td><td align="left" rowspan="1" colspan="1">20 (7.1)</td></tr><tr><td align="left" colspan="4" rowspan="1">Vascular comorbidities, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Atrial fibrillation/flutter</td><td align="left" rowspan="1" colspan="1">434 (10.8)</td><td align="left" rowspan="1" colspan="1">11 (3.9)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">3420 (85.1)</td><td align="left" rowspan="1" colspan="1">192 (68.3)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Diabetes</td><td align="left" rowspan="1" colspan="1">1535 (38.2)</td><td align="left" rowspan="1" colspan="1">66 (23.5)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Coronary heart disease</td><td align="left" rowspan="1" colspan="1">998 (24.8)</td><td align="left" rowspan="1" colspan="1">44 (15.7)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Congestive heart failure</td><td align="left" rowspan="1" colspan="1">789 (19.6)</td><td align="left" rowspan="1" colspan="1">27 (9.6)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Chronic kidney disease</td><td align="left" rowspan="1" colspan="1">1377 (34.3)</td><td align="left" rowspan="1" colspan="1">43 (15.3)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Renal failure</td><td align="left" rowspan="1" colspan="1">1379 (34.3)</td><td align="left" rowspan="1" colspan="1">43 (15.3)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td><td align="left" rowspan="1" colspan="1">887 (21.8)</td><td align="left" rowspan="1" colspan="1">39 (13.9)</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Prior stroke</td><td align="left" rowspan="1" colspan="1">947 (24.2)</td><td align="left" rowspan="1" colspan="1">102 (36.3)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="4" rowspan="1">Additional comorbidities, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Benign headache</td><td align="left" rowspan="1" colspan="1">861 (21.4)</td><td align="left" rowspan="1" colspan="1">236 (84.0)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Substance use disorder</td><td align="left" rowspan="1" colspan="1">1524 (37.9)</td><td align="left" rowspan="1" colspan="1">137 (48.8)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Psychiatric illness</td><td align="left" rowspan="1" colspan="1">1948 (48.5)</td><td align="left" rowspan="1" colspan="1">142 (50.5)</td><td align="left" rowspan="1" colspan="1">0.506</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Alcohol use</td><td align="left" rowspan="1" colspan="1">390 (9.7)</td><td align="left" rowspan="1" colspan="1">24 (8.5)</td><td align="left" rowspan="1" colspan="1">0.804</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Drug poisoning</td><td align="left" rowspan="1" colspan="1">1174 (29.2)</td><td align="left" rowspan="1" colspan="1">70 (24.9)</td><td align="left" rowspan="1" colspan="1">0.124</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Lupus</td><td align="left" rowspan="1" colspan="1">154 (3.8)</td><td align="left" rowspan="1" colspan="1">
<xref rid="jah38832-note-0003" ref-type="table-fn">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.078</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Rheumatological disorders</td><td align="left" rowspan="1" colspan="1">304 (7.6)</td><td align="left" rowspan="1" colspan="1">12 (4.3)</td><td align="left" rowspan="1" colspan="1">0.041</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Cancer</td><td align="left" rowspan="1" colspan="1">527 (13.1)</td><td align="left" rowspan="1" colspan="1">14 (5.0)</td><td align="left" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pregnancy/puerperium</td><td align="left" rowspan="1" colspan="1">227 (5.7)</td><td align="left" rowspan="1" colspan="1">
<xref rid="jah38832-note-0003" ref-type="table-fn">*</xref>
</td><td align="left" rowspan="1" colspan="1">0.001</td></tr></tbody></table><table-wrap-foot id="jah38832-ntgp-0002"><fn id="jah38832-note-0003"><label>*</label><p>Counts suppressed to comply with privacy regulations regarding instances of &lt;11 data points per cell.</p></fn></table-wrap-foot></table-wrap><p>In Table&#160;<xref rid="jah38832-tbl-0002" ref-type="table">2</xref>, facility factors associated with a probable ED misdiagnosis are reported. We found that probable misdiagnosis was associated with presenting to a facility without an Accreditation Council for Graduate Medical Education&#8211;approved residency program (62.2% versus 70.4%; <italic toggle="yes">P</italic>=0.006), to a facility without neurological services (75.7% versus 81.2%; <italic toggle="yes">P</italic>=0.032), and to a facility that was smaller in size. Due to a lack of hospital&#8208;level identifiers for certain states in HCUP, facility&#8208;level information was unavailable for 30 of 281 (10.7%) ED encounters among patients with a probable misdiagnosis and 717 of 4485 (16%) encounters among correctly diagnosed patients. In our multivariable model including both patient and facility factors, we found that comorbid headache at the time of PRES/RCVS hospitalization was most associated with probable ED misdiagnosis (OR, 15.21 [95% CI, 10.34&#8211;22.38]).</p><table-wrap position="float" id="jah38832-tbl-0002" content-type="Table" orientation="portrait"><label>Table 2</label><caption><p>Facility&#8208;Level Differences Between Emergency Department Encounters With Versus Without Probable Posterior Reversible Encephalopathy Syndrome/Reversible Cerebral Vasoconstriction Syndrome Misdiagnosis</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">No misdiagnosis (N=3768)</th><th align="left" rowspan="1" colspan="1">Probable misdiagnosis (N=251)</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1">Size based on total number of beds, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">&lt;100</td><td align="left" rowspan="1" colspan="1">288 (7.6)</td><td align="left" rowspan="1" colspan="1">53 (21.1)</td><td align="left" rowspan="3" colspan="1">&lt;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">100&#8211;499</td><td align="left" rowspan="1" colspan="1">1959 (52.0)</td><td align="left" rowspan="1" colspan="1">131 (52.2)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">&#8805;500</td><td align="left" rowspan="1" colspan="1">1521 (40.4)</td><td align="left" rowspan="1" colspan="1">67 (26.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Accreditation Council for Graduate Medical Education&#8211;approved residency, n (%)</td><td align="left" rowspan="1" colspan="1">2651 (70.4)</td><td align="left" rowspan="1" colspan="1">156 (62.2)</td><td align="left" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" colspan="4" rowspan="1">Facility control, n (%)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Government</td><td align="left" rowspan="1" colspan="1">405 (10.7)</td><td align="left" rowspan="1" colspan="1">20 (8.0)</td><td align="left" rowspan="3" colspan="1">0.223</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Nonprofit</td><td align="left" rowspan="1" colspan="1">2860 (75.9)</td><td align="left" rowspan="1" colspan="1">205 (81.7)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">For&#8208;profit</td><td align="left" rowspan="1" colspan="1">503 (13.4)</td><td align="left" rowspan="1" colspan="1">26 (10.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Neurological services at hospital</td><td align="left" rowspan="1" colspan="1">3060 (81.2)</td><td align="left" rowspan="1" colspan="1">190 (75.7)</td><td align="left" rowspan="1" colspan="1">0.032</td></tr></tbody></table></table-wrap><p>After adjustment for demographics and all comorbidities, probable misdiagnosis was not significantly associated with ischemic stroke (OR, 1.33 [95% CI, 0.75&#8211;2.35]), intracerebral hemorrhage (OR, 1.18 [95% CI, 0.57&#8211;2.45]), or SAH (OR, 1.28 [95% CI, 0.76&#8211;2.17]) documented during the PRES/RCVS hospitalization. Probable misdiagnosis was negatively related to length of stay such that the average length of stay was 2&#8201;days shorter for patients with a probable misdiagnosis after adjustment for demographics and comorbidities (<italic toggle="yes">P</italic>=0.003). There was no statistically significant association between probable misdiagnosis and discharge destination (OR, 0.71 [95% CI, 0.49&#8211;1.02]) after adjustment.</p></sec><sec sec-type="discussion" id="jah38832-sec-0014"><title>Discussion</title><p>In a large, heterogeneous cohort, we found that &#8776;1 of every 20 patients with PRES/RCVS had a probable misdiagnosis at a preceding ED visit. Probable misdiagnosis was more common among younger patients, women, and those with prior stroke, substance use disorder, or comorbid headache. We also found that preceding probable ED misdiagnoses more often occurred at hospitals that were smaller and without residency training programs or neurological services. Probable misdiagnosis in the ED was not significantly associated with a higher likelihood of ischemic stroke, intracerebral hemorrhage, or SAH during subsequent PRES/RCVS hospitalization.</p><p>The proportion of patients with PRES/RCVS estimated to have a preceding ED misdiagnosis is similar to diagnostic error rates reported with other uncommon cerebrovascular diseases, such as cerebral venous thrombosis (3.6%)<xref rid="jah38832-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> and cervicocephalic artery dissection (3.1%).<xref rid="jah38832-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> However, in a large study of patients hospitalized for more common cerebrovascular conditions (ischemic stroke, TIA, intracerebral hemorrhage, and SAH), rates of probable ED misdiagnosis were lower (1.2%).<xref rid="jah38832-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> Patients with rare cerebrovascular conditions thus may be at higher risk of ED misdiagnosis than those with more common ones. In our study, patients with a final diagnosis of RCVS more often had a preceding ED treat&#8208;and&#8208;release visit than those diagnosed with PRES. Increasing physician awareness and education about cerebral dysregulation syndromes or improving ED access to neurologists may be ways to improve PRES/RCVS diagnostic accuracy. As in our study, low&#8208;volume and nonteaching hospitals without access to neurological consultation are facility&#8208;level features that have previously been associated with diagnostic error.<xref rid="jah38832-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>
</p><p>Our results regarding patient factors associated with probable ED misdiagnosis of PRES/RCVS add to the growing literature identifying sex&#8208;related differences in diagnosis among patients with cerebrovascular disease.<xref rid="jah38832-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> In a prior study of ED stroke misdiagnosis, male sex was associated with a lower odds of misdiagnosis<xref rid="jah38832-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> and, in a separate cohort study, women were underdiagnosed with TIA/minor stroke when they presented acutely with neurological symptoms.<xref rid="jah38832-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> Further research to improve diagnosis in women with PRES/RCVS and other cerebrovascular conditions is warranted and may represent an important opportunity to reduce disparities in cerebrovascular disease. Additionally, based on our study results, developing targeted strategies to improve diagnostic accuracy of PRES/RCVS among patients with a prior stroke or comorbid headache complaints may be useful. Such strategies may also be impactful for patients with other cerebrovascular diseases, as our prior work has similarly found that both patients with a history of stroke<xref rid="jah38832-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> and those with a history of headache<xref rid="jah38832-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> are at increased risk of missed and delayed diagnosis of cerebrovascular disease in the ED. Based on our study findings, increased suspicion for PRES/RCVS in young ED patients presenting with neurological symptoms may be warranted, especially in those for whom there may be a temptation to defer workup to the outpatient setting (eg, those with commercial insurance and easy access to outpatient care). While associations between substance abuse, mental health issues, and misdiagnosis of myocardial infarction in the ED have been previously found,<xref rid="jah38832-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> the ways in which substance use disorder may impact diagnostic accuracy in neurological disease require further study.</p><p>We did not find a statistically significant relationship between probable PRES/RCVS misdiagnosis and the adverse clinical outcomes we evaluated for in this study. Instead, we actually found that length of stay during PRES/RCVS hospitalization was significantly shorter for patients with a probable ED misdiagnosis. Based on prior studies,<xref rid="jah38832-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="jah38832-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> a plausible explanation for our results regarding the effect of probable ED misdiagnosis on adverse outcomes is that many PRES/RCVS patients erroneously sent home from the ED had less severe disease or had fewer medical comorbidities than patients with PRES/RCVS who were initially hospitalized. Results from Symptom&#8211;Disease Pair Analysis of Diagnostic Error analyses must be interpreted carefully with the understanding that, when assessing the effect of misdiagnosis on clinical outcomes, what would have happened had a diagnostic error not occurred is of central importance, and this counterfactual is difficult to assess without detailed baseline prognostic data.<xref rid="jah38832-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> In the current study, our inability to determine the clinical severity of index ED presentations among included patients represents an important limitation of our results regarding adverse outcomes at PRES/RCVS hospitalization. While we did not find a significantly higher likelihood of stroke or SAH among patients with PRES/RCVS with a preceding ED misdiagnosis, patients who experienced ED misdiagnosis may still have been harmed by the error.<xref rid="jah38832-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref>
</p><p>Our study has a number of additional limitations. To begin with, it is possible that we may have underestimated the rate of PRES/RCVS misdiagnosis in the ED because we did not capture patients who failed to return for medical evaluation after an ED visit, patients who were never correctly diagnosed with PRES/RCVS when they returned, and patients who died before an accurate diagnosis could be made. Alternatively, we may have overestimated rates of misdiagnosis as some ED treat&#8208;and&#8208;release visits in the 14&#8201;days before PRES/RCVS hospitalization may have been completely unrelated to cerebrovascular dysregulation. However, this latter possibility seems unlikely given the temporal relationships we found between encounters. Second, we may have overestimated the number of patients diagnosed with PRES/RCVS in a timely and accurate fashion because we considered any patients without an ED treat&#8208;and&#8208;release visit in the 14&#8201;days before PRES/RCVS hospitalization to be correctly diagnosed. It is possible that some of the patients we categorized as correctly diagnosed may have had a delayed diagnosis of PRES/RCVS during their hospitalization or may have been initially misdiagnosed at a non&#8208;ED encounter (eg, outpatient office visit, urgent care visit) or initially presented to an ED in a state not included in our HCUP database. Third, given the relative rarity of probable ED misdiagnosis that we found, our study is likely underpowered. Fourth, missing information regarding facility&#8208;level factors may have biased our results regarding which factors were associated with diagnostic error, as some states systematically lacked data regarding facilities. Finally, it is important to note that medication and imaging data were not available in HCUP, which limits our ability to fully characterize our study cohort.</p></sec><sec sec-type="conclusions" id="jah38832-sec-0015"><title>Conclusions</title><p>Among patients hospitalized for PRES/RCVS, we found that &#8776;1 of every 20 patients were probably misdiagnosed at a preceding ED visit. While we identified certain patient&#8208; and facility&#8208;level factors associated with ED misdiagnosis of PRES/RCVS, additional research is needed to identify targetable pathways to improve diagnostic accuracy among ED patients with these relatively rare but potentially disabling cerebrovascular disorders.</p></sec><sec id="jah38832-sec-0016"><title>Sources of Funding</title><p>A.L. Liberman is supported by National Institute of Neurological Disorders and Stroke research grant K23NS10764. N.S. Parikh is supported by National Institute on Aging research grant K23AG073524 and the Florence Gould Foundation.</p></sec><sec id="jah38832-sec-0017"><title>Disclosures</title><p>Dr Parikh is the site blinded outcome assessor for the Medtronic, A Study of the Embolization of the Middle Meningeal Artery With ONYX<sup>TM</sup> Liquid Embolic System In the Treatment of Subacute and Chronic Subdural HEmatoma (EMBOLISE) trial and has received personal fees for medicolegal consulting. Dr Kamel serves as a principal investigator for the National Institutes of Health&#8211;funded ARCADIA (Atrial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke) trial (National Institute of Neurological Disorders and Stroke u01ns095869), which receives in&#8208;kind study drug from the BMS&#8211;Pfizer alliance for eliquis and ancillary study support from Roche Diagnostics; as deputy editor for <italic toggle="yes">JAMA Neurology</italic>; on clinical trial steering/executive committees for Medtronic, Janssen, and Javelin Medical; and on end point adjudication committees for Novonordisk and Boehringer&#8211;Ingelheim, not directly related to this work. Drs Merkler and Navi have received personal fees for medicolegal consulting. The remaining authors have no disclosures to report.</p></sec></body><back><ref-list content-type="cited-references" id="jah38832-bibl-0001"><title>References</title><ref id="jah38832-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jah38832-cit-0001"><string-name name-style="western"><surname>Bartynski</surname><given-names>WS</given-names></string-name>, <string-name name-style="western"><surname>Boardman</surname><given-names>JF</given-names></string-name>. <article-title>Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome</article-title>. <source>AJNR Am J Neuroradiol</source>. <year>2007</year>;<volume>28</volume>:<fpage>1320</fpage>&#8211;<lpage>1327</lpage>. doi: <pub-id pub-id-type="doi">10.3174/ajnr.A0549</pub-id><pub-id pub-id-type="pmid">17698535</pub-id><pub-id pub-id-type="pmcid">PMC7977645</pub-id></mixed-citation></ref><ref id="jah38832-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="jah38832-cit-0002"><string-name name-style="western"><surname>Fugate</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Claassen</surname><given-names>DO</given-names></string-name>, <string-name name-style="western"><surname>Cloft</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Kallmes</surname><given-names>DF</given-names></string-name>, <string-name name-style="western"><surname>Kozak</surname><given-names>OS</given-names></string-name>, <string-name name-style="western"><surname>Rabinstein</surname><given-names>AA</given-names></string-name>. <article-title>Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings</article-title>. <source>Mayo Clin Proc</source>. <year>2010</year>;<volume>85</volume>:<fpage>427</fpage>&#8211;<lpage>432</lpage>. doi: <pub-id pub-id-type="doi">10.4065/mcp.2009.0590</pub-id><pub-id pub-id-type="pmid">20435835</pub-id><pub-id pub-id-type="pmcid">PMC2861971</pub-id></mixed-citation></ref><ref id="jah38832-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="jah38832-cit-0003"><string-name name-style="western"><surname>Singhal</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Hajj&#8208;Ali</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Topcuoglu</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Fok</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Bena</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Calabrese</surname><given-names>LH</given-names></string-name>. <article-title>Reversible cerebral vasoconstriction syndromes: analysis of 139 cases</article-title>. <source>Arch Neurol</source>. <year>2011</year>;<volume>68</volume>:<fpage>1005</fpage>&#8211;<lpage>1012</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archneurol.2011.68</pub-id><pub-id pub-id-type="pmid">21482916</pub-id></mixed-citation></ref><ref id="jah38832-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jah38832-cit-0004"><string-name name-style="western"><surname>Ducros</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Boukobza</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Porcher</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Sarov</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Valade</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Bousser</surname><given-names>MG</given-names></string-name>. <article-title>The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients</article-title>. <source>Brain</source>. <year>2007</year>;<volume>130</volume>:<fpage>3091</fpage>&#8211;<lpage>3101</lpage>. doi: <pub-id pub-id-type="doi">10.1093/brain/awm256</pub-id><pub-id pub-id-type="pmid">18025032</pub-id></mixed-citation></ref><ref id="jah38832-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jah38832-cit-0005"><string-name name-style="western"><surname>Singhal</surname><given-names>AB</given-names></string-name>. <article-title>Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome as syndromes of cerebrovascular dysregulation</article-title>. <source>Continuum (Minneap Minn)</source>. <year>2021</year>;<volume>27</volume>:<fpage>1301</fpage>&#8211;<lpage>1320</lpage>. doi: <pub-id pub-id-type="doi">10.1212/CON.0000000000001037</pub-id><pub-id pub-id-type="pmid">34618761</pub-id></mixed-citation></ref><ref id="jah38832-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jah38832-cit-0006"><string-name name-style="western"><surname>Fugate</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Rabinstein</surname><given-names>AA</given-names></string-name>. <article-title>Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions</article-title>. <source>Lancet Neurol</source>. <year>2015</year>;<volume>14</volume>:<fpage>914</fpage>&#8211;<lpage>925</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(15)00111-8</pub-id><pub-id pub-id-type="pmid">26184985</pub-id></mixed-citation></ref><ref id="jah38832-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jah38832-cit-0007"><string-name name-style="western"><surname>Magid&#8208;Bernstein</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Omran</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Parikh</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Merkler</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Navi</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Kamel</surname><given-names>H</given-names></string-name>. <article-title>RCVS: symptoms, incidence, and resource utilization in a population&#8208;based US cohort</article-title>. <source>Neurology</source>. <year>2021</year>;<volume>97</volume>:<fpage>e248</fpage>&#8211;<lpage>e253</lpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.0000000000012223</pub-id><pub-id pub-id-type="pmid">34050007</pub-id><pub-id pub-id-type="pmcid">PMC8302148</pub-id></mixed-citation></ref><ref id="jah38832-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jah38832-cit-0008"><string-name name-style="western"><surname>Rocha</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Topcuoglu</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Silva</surname><given-names>GS</given-names></string-name>, <string-name name-style="western"><surname>Singhal</surname><given-names>AB</given-names></string-name>. <article-title>RCVS2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome</article-title>. <source>Neurology</source>. <year>2019</year>;<volume>92</volume>:<fpage>e639</fpage>&#8211;<lpage>e647</lpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.0000000000006917</pub-id><pub-id pub-id-type="pmid">30635475</pub-id></mixed-citation></ref><ref id="jah38832-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jah38832-cit-0009"><string-name name-style="western"><surname>Miller</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Wagner</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Hammond</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Marshall</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Barth</surname><given-names>B</given-names></string-name>. <article-title>Posterior reversible encephalopathy syndrome in the emergency department: a single center retrospective study</article-title>. <source>Am J Emerg Med</source>. <year>2021</year>;<volume>45</volume>:<fpage>61</fpage>&#8211;<lpage>64</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajem.2021.02.013</pub-id><pub-id pub-id-type="pmid">33667750</pub-id></mixed-citation></ref><ref id="jah38832-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jah38832-cit-0010"><string-name name-style="western"><surname>Liberman</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Navi</surname><given-names>BB</given-names></string-name>, <string-name name-style="western"><surname>Esenwa</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>NT</given-names></string-name>, <string-name name-style="western"><surname>Labovitz</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Kamel</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Merkler</surname><given-names>AE</given-names></string-name>. <article-title>Misdiagnosis of cervicocephalic artery dissection in the emergency department</article-title>. <source>Stroke</source>. <year>2020</year>;<volume>51</volume>:<fpage>1876</fpage>&#8211;<lpage>1878</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.120.029390</pub-id><pub-id pub-id-type="pmid">32295512</pub-id><pub-id pub-id-type="pmcid">PMC7253341</pub-id></mixed-citation></ref><ref id="jah38832-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="jah38832-cit-0011"><string-name name-style="western"><surname>Tarnutzer</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>SH</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Edlow</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Newman&#8208;Toker</surname><given-names>DE</given-names></string-name>. <article-title>ED misdiagnosis of cerebrovascular events in the era of modern neuroimaging: a meta&#8208;analysis</article-title>. <source>Neurology</source>. <year>2017</year>;<volume>88</volume>:<fpage>1468</fpage>&#8211;<lpage>1477</lpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.0000000000003814</pub-id><pub-id pub-id-type="pmid">28356464</pub-id><pub-id pub-id-type="pmcid">PMC5386439</pub-id></mixed-citation></ref><ref id="jah38832-bib-0012"><label>12</label><mixed-citation publication-type="book" id="jah38832-cit-0012"><collab collab-type="authors">National Academies of Sciences, Engineering, and Medicine</collab>
. <source>Improving Diagnosis in Health Care</source>. <publisher-name>The National Academies Press</publisher-name>; <year>2015</year>. doi: <pub-id pub-id-type="doi">10.17226/21794</pub-id></mixed-citation></ref><ref id="jah38832-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="jah38832-cit-0013"><string-name name-style="western"><surname>Newman&#8208;Toker</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Schaffer</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Yu&#8208;Moe</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Nassery</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Saber Tehrani</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Clemens</surname><given-names>GD</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Fanai</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Siegal</surname><given-names>D</given-names></string-name>. <article-title>Serious misdiagnosis&#8208;related harms in malpractice claims: the "big three"&#8211;vascular events, infections, and cancers</article-title>. <source>Diagnosis (Berl)</source>. <year>2019</year>;<volume>6</volume>:<fpage>227</fpage>&#8211;<lpage>240</lpage>. doi: <pub-id pub-id-type="doi">10.1515/dx-2019-0019</pub-id><pub-id pub-id-type="pmid">31535832</pub-id></mixed-citation></ref><ref id="jah38832-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jah38832-cit-0014"><string-name name-style="western"><surname>von Elm</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Altman</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Egger</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Pocock</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Gotzsche</surname><given-names>PC</given-names></string-name>, <string-name name-style="western"><surname>Vandenbroucke</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Initiative</surname><given-names>S</given-names></string-name>. <article-title>The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title>. <source>Lancet</source>. <year>2007</year>;<volume>370</volume>:<fpage>1453</fpage>&#8211;<lpage>1457</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(07)61602-X</pub-id><pub-id pub-id-type="pmid">18064739</pub-id></mixed-citation></ref><ref id="jah38832-bib-0015"><label>15</label><mixed-citation publication-type="miscellaneous" id="jah38832-cit-0015"><string-name name-style="western"><surname>Barrett</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Steiner</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Andrews</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kassed</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Nagamine</surname><given-names>M</given-names></string-name>; <collab collab-type="authors">Methodological Issues when Studying Readmissions and Revisits Using Hospital Adminstrative Data</collab>
. <article-title>HCUP Methods Series Report # 2011&#8211;01. March 9, 2011. U.S. Agency for Healthcare Research and Quality</article-title>. <year>2011</year> Accessed May 2, 2022. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.hcupus.ahrq.gov/reports/methods/methods.jsp" ext-link-type="uri">http://www.hcupus.ahrq.gov/reports/methods/methods.jsp</ext-link>.</mixed-citation></ref><ref id="jah38832-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jah38832-cit-0016"><string-name name-style="western"><surname>Newman&#8208;Toker</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Moy</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Valente</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Coffey</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Hines</surname><given-names>AL</given-names></string-name>. <article-title>Missed diagnosis of stroke in the emergency department: a cross&#8208;sectional analysis of a large population&#8208;based sample</article-title>. <source>Diagnosis (Berl)</source>. <year>2014</year>;<volume>1</volume>:<fpage>155</fpage>&#8211;<lpage>166</lpage>. doi: <pub-id pub-id-type="doi">10.1515/dx-2013-0038</pub-id><pub-id pub-id-type="pmid">28344918</pub-id><pub-id pub-id-type="pmcid">PMC5361750</pub-id></mixed-citation></ref><ref id="jah38832-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jah38832-cit-0017"><string-name name-style="western"><surname>Liberman</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Newman&#8208;Toker</surname><given-names>DE</given-names></string-name>. <article-title>Symptom&#8208;disease pair analysis of diagnostic error (SPADE): a conceptual framework and methodological approach for unearthing misdiagnosis&#8208;related harms using big data</article-title>. <source>BMJ Qual Saf</source>. <year>2018</year>;<volume>27</volume>:<fpage>557</fpage>&#8211;<lpage>566</lpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjqs-2017-007032</pub-id><pub-id pub-id-type="pmcid">PMC6049698</pub-id><pub-id pub-id-type="pmid">29358313</pub-id></mixed-citation></ref><ref id="jah38832-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jah38832-cit-0018"><string-name name-style="western"><surname>Liberman</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Gialdini</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Bakradze</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Chatterjee</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kamel</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Merkler</surname><given-names>AE</given-names></string-name>. <article-title>Misdiagnosis of cerebral vein thrombosis in the emergency department</article-title>. <source>Stroke</source>. <year>2018</year>;<volume>49</volume>:<fpage>1504</fpage>&#8211;<lpage>1506</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.118.021058</pub-id><pub-id pub-id-type="pmid">29695468</pub-id><pub-id pub-id-type="pmcid">PMC5970977</pub-id></mixed-citation></ref><ref id="jah38832-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jah38832-cit-0019"><string-name name-style="western"><surname>Parauda</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Salehi Omran</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Schweitzer</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Murthy</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Merkler</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Navi</surname><given-names>BB</given-names></string-name>, <string-name name-style="western"><surname>Iadecola</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kamel</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Parikh</surname><given-names>NS</given-names></string-name>. <article-title>Risk of stroke after posterior reversible encephalopathy syndrome</article-title>. <source>Stroke</source>. <year>2022</year>;<volume>53</volume>:<fpage>3313</fpage>&#8211;<lpage>3319</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.122.038673</pub-id><pub-id pub-id-type="pmid">35942880</pub-id><pub-id pub-id-type="pmcid">PMC9613524</pub-id></mixed-citation></ref><ref id="jah38832-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jah38832-cit-0020"><string-name name-style="western"><surname>Kokotailo</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Hill</surname><given-names>MD</given-names></string-name>. <article-title>Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10</article-title>. <source>Stroke</source>. <year>2005</year>;<volume>36</volume>:<fpage>1776</fpage>&#8211;<lpage>1781</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.STR.0000174293.17959.a1</pub-id><pub-id pub-id-type="pmid">16020772</pub-id></mixed-citation></ref><ref id="jah38832-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jah38832-cit-0021"><string-name name-style="western"><surname>Boehme</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Esenwa</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Elkind</surname><given-names>MS</given-names></string-name>. <article-title>Stroke risk factors, genetics, and prevention</article-title>. <source>Circ Res</source>. <year>2017</year>;<volume>120</volume>:<fpage>472</fpage>&#8211;<lpage>495</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.308398</pub-id><pub-id pub-id-type="pmid">28154098</pub-id><pub-id pub-id-type="pmcid">PMC5321635</pub-id></mixed-citation></ref><ref id="jah38832-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jah38832-cit-0022"><string-name name-style="western"><surname>Portegies</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Lahousse</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Joos</surname><given-names>GF</given-names></string-name>, <string-name name-style="western"><surname>Hofman</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Koudstaal</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Stricker</surname><given-names>BH</given-names></string-name>, <string-name name-style="western"><surname>Brusselle</surname><given-names>GG</given-names></string-name>, <string-name name-style="western"><surname>Ikram</surname><given-names>MA</given-names></string-name>. <article-title>Chronic obstructive pulmonary disease and the risk of stroke. The Rotterdam study</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2016</year>;<volume>193</volume>:<fpage>251</fpage>&#8211;<lpage>258</lpage>. doi: <pub-id pub-id-type="doi">10.1164/rccm.201505-0962OC</pub-id><pub-id pub-id-type="pmid">26414484</pub-id></mixed-citation></ref><ref id="jah38832-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jah38832-cit-0023"><string-name name-style="western"><surname>Masson</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Webster</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Hong</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Turner</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lindley</surname><given-names>RI</given-names></string-name>, <string-name name-style="western"><surname>Craig</surname><given-names>JC</given-names></string-name>. <article-title>Chronic kidney disease and the risk of stroke: a systematic review and meta&#8208;analysis</article-title>. <source>Nephrol Dial Transplant</source>. <year>2015</year>;<volume>30</volume>:<fpage>1162</fpage>&#8211;<lpage>1169</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ndt/gfv009</pub-id><pub-id pub-id-type="pmid">25681099</pub-id></mixed-citation></ref><ref id="jah38832-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jah38832-cit-0024"><string-name name-style="western"><surname>Ali</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>van Os</surname><given-names>HJA</given-names></string-name>, <string-name name-style="western"><surname>van der Weerd</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Schoones</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Heymans</surname><given-names>MW</given-names></string-name>, <string-name name-style="western"><surname>Kruyt</surname><given-names>ND</given-names></string-name>, <string-name name-style="western"><surname>Visser</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Wermer</surname><given-names>MJH</given-names></string-name>. <article-title>Sex differences in presentation of stroke: a systematic review and meta&#8208;analysis</article-title>. <source>Stroke</source>. <year>2022</year>;<volume>53</volume>:<fpage>345</fpage>&#8211;<lpage>354</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.120.034040</pub-id><pub-id pub-id-type="pmid">34903037</pub-id><pub-id pub-id-type="pmcid">PMC8785516</pub-id></mixed-citation></ref><ref id="jah38832-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="jah38832-cit-0025"><string-name name-style="western"><surname>Yu</surname><given-names>AYX</given-names></string-name>, <string-name name-style="western"><surname>Penn</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Lesperance</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Croteau</surname><given-names>NS</given-names></string-name>, <string-name name-style="western"><surname>Balshaw</surname><given-names>RF</given-names></string-name>, <string-name name-style="western"><surname>Votova</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Bibok</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Penn</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Saly</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Hegedus</surname><given-names>J</given-names></string-name>, et al. <article-title>Sex differences in presentation and outcome after an acute transient or minor neurologic event</article-title>. <source>JAMA Neurol</source>. <year>2019</year>;<volume>76</volume>:<fpage>962</fpage>&#8211;<lpage>968</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamaneurol.2019.1305</pub-id><pub-id pub-id-type="pmid">31114842</pub-id><pub-id pub-id-type="pmcid">PMC6537759</pub-id></mixed-citation></ref><ref id="jah38832-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jah38832-cit-0026"><string-name name-style="western"><surname>Liberman</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Hassoon</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Fanai</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Badihian</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rupani</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Peterson</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Sebestyen</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Lipton</surname><given-names>RB</given-names></string-name>, et al. <article-title>Cerebrovascular disease hospitalizations following emergency department headache visits: a nested case&#8208;control study</article-title>. <source>Acad Emerg Med</source>. <year>2022</year>;<volume>29</volume>:<fpage>41</fpage>&#8211;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1111/acem.14353</pub-id><pub-id pub-id-type="pmid">34309135</pub-id><pub-id pub-id-type="pmcid">PMC8766867</pub-id></mixed-citation></ref><ref id="jah38832-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="jah38832-cit-0027"><string-name name-style="western"><surname>Liberman</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Bakradze</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>McHugh</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Esenwa</surname><given-names>CC</given-names></string-name>, <string-name name-style="western"><surname>Lipton</surname><given-names>RB</given-names></string-name>. <article-title>Assessing diagnostic error in cerebral venous thrombosis via detailed chart review</article-title>. <source>Diagnosis (Berl)</source>. <year>2019</year>;<volume>6</volume>:<fpage>361</fpage>&#8211;<lpage>367</lpage>. doi: <pub-id pub-id-type="doi">10.1515/dx-2019-0003</pub-id><pub-id pub-id-type="pmid">31271550</pub-id></mixed-citation></ref><ref id="jah38832-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="jah38832-cit-0028"><string-name name-style="western"><surname>Sharp</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Pallegadda</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Baecker</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Park</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Nassery</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Hassoon</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Peterson</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Pitts</surname><given-names>SI</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></string-name>, et al. <article-title>Are mental health and substance use disorders risk factors for missed acute myocardial infarction diagnoses among chest pain or dyspnea encounters in the emergency department?</article-title><source>Ann Emerg Med</source>. <year>2022</year>;<volume>79</volume>:<fpage>93</fpage>&#8211;<lpage>101</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.annemergmed.2021.08.016</pub-id><pub-id pub-id-type="pmid">34607739</pub-id></mixed-citation></ref><ref id="jah38832-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="jah38832-cit-0029"><string-name name-style="western"><surname>Ferro</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Canhao</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Stam</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Bousser</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Barinagarrementeria</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Massaro</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Ducrocq</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Kasner</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Investigators</surname><given-names>I</given-names></string-name>. <article-title>Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome</article-title>. <source>Stroke</source>. <year>2009</year>;<volume>40</volume>:<fpage>3133</fpage>&#8211;<lpage>3138</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.109.553891</pub-id><pub-id pub-id-type="pmid">19608994</pub-id></mixed-citation></ref><ref id="jah38832-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jah38832-cit-0030"><string-name name-style="western"><surname>Newman&#8208;Toker</surname><given-names>DE</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Nassery</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Saber Tehrani</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Schaffer</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Yu&#8208;Moe</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Clemens</surname><given-names>GD</given-names></string-name>, <string-name name-style="western"><surname>Fanai</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Siegal</surname><given-names>D</given-names></string-name>. <article-title>Rate of diagnostic errors and serious misdiagnosis&#8208;related harms for major vascular events, infections, and cancers: toward a national incidence estimate using the &#8220;big three.&#8221;</article-title><source>Diagnosis (Berl)</source>. <year>2021</year>;<volume>8</volume>:<fpage>67</fpage>&#8211;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1515/dx-2019-0104</pub-id><pub-id pub-id-type="pmid">32412440</pub-id></mixed-citation></ref><ref id="jah38832-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jah38832-cit-0031"><string-name name-style="western"><surname>Newman&#8208;Toker</surname><given-names>DE</given-names></string-name>. <article-title>A unified conceptual model for diagnostic errors: underdiagnosis, overdiagnosis, and misdiagnosis</article-title>. <source>Diagnosis (Berl)</source>. <year>2014</year>;<volume>1</volume>:<fpage>43</fpage>&#8211;<lpage>48</lpage>. doi: <pub-id pub-id-type="doi">10.1515/dx-2013-0027</pub-id><pub-id pub-id-type="pmid">28367397</pub-id><pub-id pub-id-type="pmcid">PMC5373075</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>